* Immunomedics Inc., of Morris Plains, N.J., and NeoRx Corp., ofSeattle, settled a patent infringement lawsuit. Under the terms, NeoRxgave Immunomedics a non-exclusive, royalty-free license to U.S.patent No. 4,877,868 for all of Immunomedics' imaging products, andImmunomedics gave NeoRx a non-exclusive, royalty-free license toU.S. patent 4,331,641 for certain NeoRx imaging products. No cashdamages were involved.* Inflazyme Pharmaceuticals Ltd., of Vancouver, Canada, plans to raise$60,000 through the private placement of 100,000 shares at 60 centsper share. The placement also includes non-transferable share purchasewarrants for another 100,000 shares, exercisable for two years at 80cents per share.

(c) 1997 American Health Consultants. All rights reserved.